| For: | Kozuch PL, Hanauer SB. Treatment of inflammatory bowel disease: A review of medical therapy. World J Gastroenterol 2008; 14(3): 354-377 [PMID: 18200659 DOI: 10.3748/wjg.14.354] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i3/354.htm |
| Number | Citing Articles |
| 1 |
Rebekah Jaung, Jason Robertson, Ryash Vather, David Rowbotham, Ian P. Bissett. Changes in the approach to acute diverticulitis. ANZ Journal of Surgery 2015; 85(10) doi: 10.1111/ans.13233
|
| 2 |
Fernanda Brito, Cyrla Zaltman, Ana T.P. Carvalho, Ricardo G. Fischer, Rutger Persson, Anders Gustafsson, Carlos M.S. Figueredo. Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis. European Journal of Gastroenterology & Hepatology 2013; 25(2) doi: 10.1097/MEG.0b013e32835a2b70
|
| 3 |
Yuki Moritoki, Zhe‐Xiong Lian, Keith Lindor, Joseph Tuscano, Koichi Tsuneyama, Weici Zhang, Yoshiyuki Ueno, Robert Dunn, Marilyn Kehry, Ross L. Coppel, Ian R. Mackay, M. Eric Gershwin. B‐cell depletion with anti‐CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor‐β receptor II dominant negative mice†. Hepatology 2009; 50(6) doi: 10.1002/hep.23238
|
| 4 |
Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Amy Lightner, Anya Platt, Rutger Jacobs, Sarah Reardon, Ellen Kane, Jonathan Sack, Daniel Hommes. Patient Experiences and Outcomes of a Telehealth Clinical Care Pathway for Postoperative Inflammatory Bowel Disease Patients. Telemedicine and e-Health 2020; 26(7) doi: 10.1089/tmj.2019.0102
|
| 5 |
Mohammed Al-Beltagi, Nermin K Saeed, Prabu Kumar Chokkalingam Mani, Adel S Bediwy, Reem Elbeltagi. Inflammatory bowel disease in paediatrics: Navigating the old challenges and emerging frontiers. World Journal of Gastroenterology 2025; 31(35): 111934 doi: 10.3748/wjg.v31.i35.111934
|
| 6 |
Giuseppe Biscaglia, Annamaria Gentile, Paola Parente, Annamaria Calvo, Rosanna Fontana, Antonio Continisio, Anna Laura Pia Di Brina, Davide Ciardiello, Gillian McIlwain, Anna Latiano, Francesco Perri, Orazio Palmieri. Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation. Nutrients 2025; 17(23) doi: 10.3390/nu17233788
|
| 7 |
Priyanka Raju Chougule, Sukesh Narayan Sinha, Sudip Ghosh, Sangaraju Rajendra, Saikanth Varma, Suresh Challa, Manjula Bhanoori. Modulation of inflammatory and cuproptotic crosstalk by Ethyl and propyl gallate: a multi-targeted strategy against experimental colitis. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-11098-7
|
| 8 |
Rohit A. Gupta, Meha N. Motiwala, Nitin G. Dumore, Kishor R. Danao, Anjali B. Ganjare. Effect of piperine on inhibition of FFA induced TLR4 mediated inflammation and amelioration of acetic acid induced ulcerative colitis in mice. Journal of Ethnopharmacology 2015; 164 doi: 10.1016/j.jep.2015.01.039
|
| 9 |
Yeonsil Yu, Eun Mi Song, Ko Eun Lee, Yang-Hee Joo, Seong-Eun Kim, Chang Mo Moon, Ha Yeong Kim, Sung-Ae Jung, Inho Jo, Hossam M. M. Arafa. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0183141
|
| 10 |
Wing-Yan Wong, Magnolia Muk-Lan Lee, Brandon Dow Chan, Victor Wan-San Ma, Wenchun Zhang, Timothy Tak-Chun Yip, Wing-Tak Wong, William Chi-Shing Tai. Gynostemma pentaphyllumsaponins attenuate inflammationin vitroandin vivoby inhibition of NF-κB and STAT3 signaling. Oncotarget 2017; 8(50) doi: 10.18632/oncotarget.20997
|
| 11 |
Kevin S. Currie, Leena Patel, Kassandra F. Sedillo. Small-molecule agents for the treatment of inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters 2019; 29(16) doi: 10.1016/j.bmcl.2019.06.042
|
| 12 |
Ana Melero, Christina Draheim, Steffi Hansen, Elisa Giner, Juan José Carreras, Raquel Talens-Visconti, Teresa María Garrigues, José Esteban Peris, Ma Carmen Recio, Rosa Giner, Claus-Michael Lehr. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model. European Journal of Pharmaceutics and Biopharmaceutics 2017; 119 doi: 10.1016/j.ejpb.2017.07.004
|
| 13 |
Amit D Kandhare, Kiran S Raygude, Pinaki Ghosh, Arvindkumar E Ghule, Tejas P Gosavi, Sachin L Badole, Subhash L Bodhankar. Effect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats. Asian Pacific Journal of Tropical Biomedicine 2012; 2(5) doi: 10.1016/S2221-1691(12)60053-7
|
| 14 |
N. Manceñido Marcos. Medicina alternativa y complementaria en la enfermedad inflamatoria intestinal. Enfermedad Inflamatoria Intestinal al Día 2015; 14(2) doi: 10.1016/j.eii.2015.06.006
|
| 15 |
Ken Cadwell, Thaddeus S. Stappenbeck, Herbert W. Virgin. Autophagy in Infection and Immunity. Current Topics in Microbiology and Immunology 2009; 335 doi: 10.1007/978-3-642-00302-8_7
|
| 16 |
Mithun Vishwanath K Patil, Amit D Kandhare, Sucheta D Bhise. Effect of aqueous extract of Cucumis sativus Linn. fruit in ulcerative colitis in laboratory animals. Asian Pacific Journal of Tropical Biomedicine 2012; 2(2) doi: 10.1016/S2221-1691(12)60344-X
|
| 17 |
Corinne Cayatte, Barbara Joyce-Shaikh, Felix Vega, Katia Boniface, Jeffrey Grein, Erin Murphy, Wendy M Blumenschein, Smiley Chen, Maria-Christina Malinao, Beth Basham, Robert H Pierce, Edward P Bowman, Brent S McKenzie, Charles O Elson, William A Faubion, Rene de Waal Malefyt, Robert A Kastelein, Daniel Cua, Terrill K McClanahan, Maribel Beaumont. Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 2012; 3(2) doi: 10.1038/ctg.2012.2
|
| 18 |
Yi Li, Jianping Chen, Andrew A Bolinger, Haiying Chen, Zhiqing Liu, Yingzi Cong, Allan R Brasier, Irina V Pinchuk, Bing Tian, Jia Zhou. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2021; 27(Supplement_2) doi: 10.1093/ibd/izab190
|
| 19 |
D A Hill, C Hoffmann, M C Abt, Y Du, D Kobuley, T J Kirn, F D Bushman, D Artis. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunology 2010; 3(2) doi: 10.1038/mi.2009.132
|
| 20 |
Hong Mi, Feng-bin Liu, Hai-wen Li, Jiang-tao Hou, Pei-wu Li. Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-017-1794-0
|
| 21 |
Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im. Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. Intestinal Research 2023; 21(3) doi: 10.5217/ir.2023.00013
|
| 22 |
James M. Becker, Arthur F. Stucchi. Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy. Inflammatory Bowel Diseases 2009; 15(1) doi: 10.1002/ibd.20780
|
| 23 |
Robert J. Ardecky, Ekaterina V. Bobkova, Tina Kiffer-Moreira, Brock Brown, Santhi Ganji, Jiwen Zou, Ian Pass, Sonoko Narisawa, Flávia Godoy Iano, Craig Rosenstein, Anton Cheltsov, Justin Rascon, Michael Hedrick, Carlton Gasior, Anita Forster, Shenghua Shi, Russell Dahl, Stefan Vasile, Ying Su, Eduard Sergienko, Thomas D.Y. Chung, Jonathan Kaunitz, Marc F. Hoylaerts, Anthony B. Pinkerton, José Luis Millán. Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes. Bioorganic & Medicinal Chemistry Letters 2014; 24(3) doi: 10.1016/j.bmcl.2013.12.043
|
| 24 |
Saher Mahmood, Areeba Saeed, Shahid Nawaz, Maira Saleem. The Gut Microbiome in Precision Medicine. 2026; doi: 10.1016/B978-0-443-40483-2.00022-4
|
| 25 |
Clare Harris, J R Fraser Cummings. JAK1 inhibition and inflammatory bowel disease. Rheumatology 2021; 60(Supplement_2) doi: 10.1093/rheumatology/keaa896
|
| 26 |
Manjeshwar Shrinath Baliga, Nandhini Joseph, Marikunte V. Venkataranganna, Arpit Saxena, Venkatesh Ponemone, Raja Fayad. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food & Function 2012; 3(11) doi: 10.1039/c2fo30097d
|
| 27 |
Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy, Bander Balkhi. Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia. Cost Effectiveness and Resource Allocation 2019; 17(1) doi: 10.1186/s12962-019-0194-3
|
| 28 |
Mary E Sherlock, Cynthia H Seow, A Hillary Steinhart, Anne Marie Griffiths, Mary E Sherlock. Cochrane Database of Systematic Reviews. 2010; doi: 10.1002/14651858.CD007698.pub2
|
| 29 |
Wei Zhang, Yingni Pan, Shouhe Qu, Dongmei Wang, Song Cheng, Xiaoqiu Liu. Anti-Inflammatory Effects of an Extract ofPolygonum hydropiperStalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway. Mediators of Inflammation 2018; 2018 doi: 10.1155/2018/6029135
|
| 30 |
Ayokunle T Abegunde, Daniela Goyes, Umer Farooq, Amy H Luke, Elizabeth Huggins, Richard S Cooper, Lara R Dugas. The impact of physical exercise on health-related quality of life in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2023; 2023(8) doi: 10.1002/14651858.CD014537
|
| 31 |
Aki OHMI, Atsushi TSUKAMOTO, Koichi OHNO, Kazuyuki UCHIDA, Ryohei NISHIMURA, Kenjiro FUKUSHIMA, Masashi TAKAHASHI, Ko NAKASHIMA, Yasuhito FUJINO, Hajime TSUJIMOTO. A Retrospective Study of Inflammatory Colorectal Polyps in Miniature Dachshunds. Journal of Veterinary Medical Science 2012; 74(1) doi: 10.1292/jvms.11-0352
|
| 32 |
Ibrahim Zvidi, Rachel Hazazi, Shlomo Birkenfeld, Yaron Niv. The Prevalence of Crohn’s Disease in Israel: A 20-Year Survey. Digestive Diseases and Sciences 2009; 54(4) doi: 10.1007/s10620-008-0429-1
|
| 33 |
Fabiola Guzmán-Mejía, Marycarmen Godínez-Victoria, Daniel Efrain Molotla-Torres, Maria Elisa Drago-Serrano. Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus. Pharmaceuticals 2023; 16(2) doi: 10.3390/ph16020214
|
| 34 |
A.M. Binus, J. Han, A.A. Qamar, E.A. Mody, E.W. Holt, A.A. Qureshi. Associated comorbidities in psoriasis and inflammatory bowel disease. Journal of the European Academy of Dermatology and Venereology 2012; 26(5) doi: 10.1111/j.1468-3083.2011.04153.x
|
| 35 |
Dannielle Fernandes Godoi, Cristina Ribeiro Cardoso, Marcelo José Barbosa Silva, Denise Brufato Ferraz, Pauline Rossetti Provinciatto, Fernando de Queiróz Cunha, João Santana da Silva, Júlio César Voltarelli. Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease. Immunobiology 2013; 218(3) doi: 10.1016/j.imbio.2012.05.012
|
| 36 |
M Geier, L Prisciandaro, G Howarth. Handbook of Prebiotics and Probiotics Ingredients. 2009; doi: 10.1201/9781420062151.ch12
|
| 37 |
Mirjam Severs, Peter N. P. A. Zuithoff, Marie-Josée J. Mangen, Mirthe E. van der Valk, Peter D. Siersema, Herma H. Fidder, Bas Oldenburg. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(9) doi: 10.1097/MIB.0000000000000853
|
| 38 |
Samba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, Daniel Cheng, Jakob Begun, Charlotte Keung, Daniel Van Langenberg, Lena Thin, Tamara Mogilevski, Peter De Cruz, Graham Radford-Smith, Emma Flanagan, Sally Bell, Soleiman Kashkooli, Miles Sparrow, Simon Ghaly, Peter Bampton, Elise Sawyer, Susan Connor, Quart-ul-ain Rizvi, Jane M Andrews, Gillian Mahy, Paola Chivers, Simon Travis, Ian Craig Lawrance. Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford. World Journal of Gastroenterology 2020; 26(30): 4428-4441 doi: 10.3748/wjg.v26.i30.4428
|
| 39 |
Ruixue Liu, Yongchao Li, Bo Zhang. The effects of konjac oligosaccharide on TNBS-induced colitis in rats. International Immunopharmacology 2016; 40 doi: 10.1016/j.intimp.2016.08.040
|
| 40 |
Aroj Bhattarai, Wojciech Kowalczyk, Thanh Ngoc Tran. A literature review on large intestinal hyperelastic constitutive modeling. Clinical Biomechanics 2021; 88 doi: 10.1016/j.clinbiomech.2021.105445
|
| 41 |
Farhad Mehrtash. Sustained Crohn’s Disease Remission with an Exclusive Elemental and Exclusion Diet: A Case Report. Gastrointestinal Disorders 2021; 3(3) doi: 10.3390/gidisord3030014
|
| 42 |
Robel Tadesse, Biniam Ewnte, Kale’ab Tesfaye. Perforated ileum as the initial presentation of Crohn's disease, a case report. International Journal of Surgery Case Reports 2022; 97(C) doi: 10.1016/j.ijscr.2022.107305
|
| 43 |
Megan Crowe, Sangmin Lee, Cynthia H Seow, Gilaad G Kaplan, Amy Metcalfe, Eric I Benchimol, M Ellen Kuenzig. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012711
|
| 44 |
Qiong Wang, Chao Jiang, Xiao Zheng, Xuanxuan Zhu, Shihai Yan, Haidan Wang, Rui Fu, Hongwei Fan, Yugen Chen. Insight into the pharmacokinetic behavior of tanshinone IIA in the treatment of Crohn’s disease: comparative data for tanshinone IIA and its two glucuronidated metabolites in normal and recurrent colitis models after oral administration. Xenobiotica 2017; 47(1) doi: 10.3109/00498254.2016.1160158
|
| 45 |
Marc Schwartz, Russell Cohen. Optimizing conventional therapy for inflammatory bowel disease. Current Gastroenterology Reports 2008; 10(6) doi: 10.1007/s11894-008-0106-8
|
| 46 |
Pooja Mehta, Zhaoxing Pan, Glenn T. Furuta, David Yonghyuk Kim, Edwin F. de Zoeten. Parent Perspectives on Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(6) doi: 10.1097/MPG.0000000000002847
|
| 47 |
Bharat B Aggarwal, Subash C Gupta, Bokyung Sung. Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers. British Journal of Pharmacology 2013; 169(8) doi: 10.1111/bph.12131
|
| 48 |
Russell G. A. Jones, Angela Martino. Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications. Critical Reviews in Biotechnology 2015; doi: 10.3109/07388551.2014.992388
|
| 49 |
Zhiwei Liu, Fansheng Kong, Jefferson E. Vallance, Eleana Harmel-Laws, Surya Amarachintha, Kris A. Steinbrecher, Michael J. Rosen, Sandip Bhattacharyya. Activation of TGF-β
activated kinase 1 promotes colon mucosal pathogenesis in inflammatory bowel disease. Physiological Reports 2017; 5(7) doi: 10.14814/phy2.13181
|
| 50 |
Andrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, Jyoti Chauhan, Josep Bassaganya-Riera. Oral Treatment with BT-11 Ameliorates Inflammatory Bowel Disease by Enhancing Regulatory T Cell Responses in the Gut. The Journal of Immunology 2019; 202(7) doi: 10.4049/jimmunol.1801446
|
| 51 |
M. Scott Harris, Deborah Hartman, Brenda R. Lemos, Emma C. Erlich, Sharon Spence, Sally Kennedy, Theadore Ptak, Ronald Pruitt, Severine Vermeire, Barbara S. Fox. AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial. Journal of Crohn's and Colitis 2016; 10(6) doi: 10.1093/ecco-jcc/jjw036
|
| 52 |
Jin Seok Park, Tac-Ghee Yi, Jong-Min Park, Young Min Han, Jun-Hyung Kim, Dong-Hee Shin, Seon Ji Tak, Kyuheon Lee, Youn Sook Lee, Myung-Shin Jeon, Ki-Baik Hahm, Sun U Song, Seok Hee Park. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. Journal of Clinical Biochemistry and Nutrition 2015; 57(3) doi: 10.3164/jcbn.15-56
|
| 53 |
Limin Shi, Qinlu Lin, Tao Yang, Ying Nie, Xinhua Li, Bo Liu, Junjun Shen, Ying Liang, Yiping Tang, Feijun Luo. Oral administration of Lentinus edodes β-glucans ameliorates DSS-induced ulcerative colitis in mice via MAPK-Elk-1 and MAPK-PPARγ pathways. Food & Function 2016; 7(11) doi: 10.1039/C6FO01043A
|
| 54 |
S Mondot, P Lepage, P Seksik, M Allez, X Tréton, Y Bouhnik, J F Colombel, M Leclerc, P Pochart, J Doré, P Marteau. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery. Gut 2016; 65(6) doi: 10.1136/gutjnl-2015-309184
|
| 55 |
Michelangelo Rottura, Igor Pirrotta, Domenico Antonio Giorgi, Natasha Irrera, Vincenzo Arcoraci, Federica Mannino, Rosario Campisi, Chiara Bivacqua, Laura Patanè, Giuseppe Costantino, Socrate Pallio, Walter Fries, Anna Viola, Giovanni Pallio. Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients. Biomedicines 2025; 13(3) doi: 10.3390/biomedicines13030669
|
| 56 |
Abbi R Saniabadi, Tomotaka Tanaka, Toshihide Ohmori, Koji Sawada, Takayuki Yamamoto, Hiroyuki Hanai. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World Journal of Gastroenterology 2014; 20(29): 9699-9715 doi: 10.3748/wjg.v20.i29.9699
|
| 57 |
Sandra Vidal-Lletjós, Mireille Andriamihaja, Anne Blais, Marta Grauso, Patricia Lepage, Anne-Marie Davila, Claire Gaudichon, Marion Leclerc, François Blachier, Annaïg Lan. Mucosal healing progression after acute colitis in mice. World Journal of Gastroenterology 2019; 25(27): 3572-3589 doi: 10.3748/wjg.v25.i27.3572
|
| 58 |
Babajide O. Ajayi, Isaac A. Adedara, Onyediaka C. Emeka, Praise B. Awoyinka, Opeoluwa O. Beckley, Ademoyeje A. Adeleye, Ebenezer O. Farombi. Kolaviron ameliorates chronic colitis induced by prolonged oral administration of Dextran Sulphate Sodium in Balb/c mice. European Journal of Medicinal Chemistry Reports 2022; 6 doi: 10.1016/j.ejmcr.2022.100071
|
| 59 |
Orestis Ioannidis, Angeliki Cheva, Ioannis Varnalidis, Ioannis Koutelidakis, Vasileios Papaziogas, Panagiotis Christidis, Elissavet Anestiadou, Konstantinos Aggelopoulos, Ioannis Mantzoros, Manousos George Pramateftakis, Efstathios Kotidis, Barbara Driagka, Stamatios Aggelopoulos, Evangelos J. Giamarellos-Bourboulis. The Combined Administration of Eicosapentaenoic Acid (EPA) and Gamma-Linolenic Acid (GLA) in Experimentally Induced Colitis: An Experimental Study in Rats. Journal of Clinical Medicine 2024; 13(22) doi: 10.3390/jcm13226661
|
| 60 |
Ryoki Takahashi, Takayasu Noguchi, Yoko Mizoguchi, Tadashi Shimoyama, Teruko Nakazawa, Tohru Ikuta. A Synbiotic with Tumor Necrosis Factor-αInhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury. BioMed Research International 2018; 2018 doi: 10.1155/2018/9184093
|
| 61 |
|
| 62 |
Shiyun Xian, Jiabin Zhu, Yuchen Wang, Haihan Song, Hangxiang Wang. Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice. Drug Delivery 2023; 30(1) doi: 10.1080/10717544.2023.2183821
|
| 63 |
Ajit Sood, Vandana Midha, Suresh Sharma, Neena Sood, Manu Bansal, Amandeep Thara, Pankaj Khanna. Infliximab in patients with severe steroid-refractory ulcerative colitis: Indian experience. Indian Journal of Gastroenterology 2014; 33(1) doi: 10.1007/s12664-013-0372-8
|
| 64 |
Ryan McKay, Monil Ghodasra, John Schardt, David Quan, Alex Eli Pottash, Wu Shang, Steven M. Jay, Gregory F. Payne, Matthew Wook Chang, John C. March, William E. Bentley. A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease. Bioengineering & Translational Medicine 2018; 3(3) doi: 10.1002/btm2.10113
|
| 65 |
Ana Paula da Fonseca Machado, Marina Vilar Geraldi, Roberto de Paula do Nascimento, Amanda Maria Tomazini Munhoz Moya, Teresa Vezza, Patricia Diez-Echave, Julio Juan Gálvez, Cinthia Bau Betim Cazarin, Mário Roberto Maróstica Júnior. Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Research International 2021; 140 doi: 10.1016/j.foodres.2020.110018
|
| 66 |
H.M. Gürcan, A. Razzaque Ahmed. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid. British Journal of Dermatology 2009; 161(4) doi: 10.1111/j.1365-2133.2009.09246.x
|
| 67 |
P. Martínez-Moya, M. Ortega-González, R. González, A. Anzola, B. Ocón, C. Hernández-Chirlaque, R. López-Posadas, M.D. Suárez, A. Zarzuelo, O. Martínez-Augustin, F. Sánchez de Medina. Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats. Pharmacological Research 2012; 66(2) doi: 10.1016/j.phrs.2012.04.006
|
| 68 |
Jaymin Patel, Kaushika Patel, Shreeraj Shah. Fabrication of a Dual-Triggered Natural Gum–Based Multi-Particulate Colon-Targeted Drug Delivery System of Budesonide Using the QbD Approach. Journal of Pharmaceutical Innovation 2023; 18(4) doi: 10.1007/s12247-023-09764-z
|
| 69 |
Alexandra-Chloé Villani, Denis Franchimont. The contribution of genetic studies in shifting the immunopathogenesis paradigm of Crohn’s disease. Expert Review of Clinical Immunology 2009; 5(4) doi: 10.1586/eci.09.21
|
| 70 |
Xin Liu, Jian Ming Wang, Stefan Bereswill. Iridoid Glycosides Fraction of Folium syringae Leaves Modulates NF-κB Signal Pathway and Intestinal Epithelial Cells Apoptosis in Experimental Colitis. PLoS ONE 2011; 6(9) doi: 10.1371/journal.pone.0024740
|
| 71 |
Xiaorui Cai, Shulin Zhao, De Cai, Jinhong Zheng, Zhiwei Zhu, Duncan Wei, Zhiwei Zheng, Huide Zhu, Yicun Chen. Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents. Steroids 2019; 146 doi: 10.1016/j.steroids.2019.03.012
|
| 72 |
Zhengshuo Li, Xiaoyue Zhang, Can Liu, Qiu Peng, Yangge Wu, Yuqing Wen, Run Zheng, Qun Yan, Jian Ma. Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression. Journal of Innate Immunity 2022; 14(4) doi: 10.1159/000519363
|
| 73 |
Liliana Andrade Chebli, Leonardo Duque de Miranda Chaves, Felipe Ferreira Pimentel, Dolores Martins Guerra, Renata Maria de Freitas Barros, Pedro Duarte Gaburri, Alexandre Zanini, Julio Maria Fonseca Chebli. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†. Inflammatory Bowel Diseases 2010; 16(4) doi: 10.1002/ibd.21083
|
| 74 |
ManzoorA Malik. MDR1C3435T polymorphism and inflammatory bowel disease. Saudi Journal of Gastroenterology 2015; 21(2) doi: 10.4103/1319-3767.153843
|
| 75 |
Andrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, Catherine Bienert, Jyoti Chauhan, Josep Bassaganya-Riera. Activation of NLRX1 by NX-13 Alleviates Inflammatory Bowel Disease through Immunometabolic Mechanisms in CD4+ T Cells. The Journal of Immunology 2019; 203(12) doi: 10.4049/jimmunol.1900364
|
| 76 |
Marwa M. Nagib, Mariane G. Tadros, Moushira I. ELSayed, Amani E. Khalifa. Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats. Toxicology and Applied Pharmacology 2013; 271(1) doi: 10.1016/j.taap.2013.04.026
|
| 77 |
Hiba A Al‐Kishali, Mai A Abd El Fattah, Waleed A Mohammad, Hanan S El‐Abhar. Cilostazol against 2,4,6‐trinitrobenzene sulfonic acid‐induced colitis: Effect on tight junction, inflammation, and apoptosis. JGH Open 2019; 3(4) doi: 10.1002/jgh3.12148
|
| 78 |
L. F. Azevedo, F. Magro, F. Portela, P. Lago, J. Deus, J. Cotter, I. Cremers, A. Vieira, P. Peixe, P. Caldeira, H. Lopes, R. Gonçalves, J. Reis, M. Cravo, L. Barros, P. Ministro, M. Lurdes, A. Duarte, M. Campos, L. Carvalho, A. Costa‐Pereira. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco‐epidemiological approach. Pharmacoepidemiology and Drug Safety 2010; 19(5) doi: 10.1002/pds.1930
|
| 79 |
Venkata S. Kotakadi, Yu Jin, Anne B. Hofseth, Lei Ying, Xiangli Cui, Suresh Volate, Alexander Chumanevich, Patricia A. Wood, Robert L. Price, Anna McNeal, Udai P. Singh, Narendra P. Singh, Mitzi Nagarkatti, Prakash S. Nagarkatti, Lydia E. Matesic, Karine Auclair, Michael J. Wargovich, Lorne J. Hofseth. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 2008; 29(9) doi: 10.1093/carcin/bgn143
|
| 80 |
A Parikh, E Fedyk, D Soler, T Wyant, V Kadambi, T Leach, C Milch, I Fox. Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to the alpha4beta7 integrin. Inflammatory Bowel Diseases 2008; 14 doi: 10.1097/00054725-200812003-00060
|
| 81 |
Luciano Cazzato, Claudia Citarella, Margherita Casanova, Angela Tullo, Maria Luigia Iaculli, Vincenza D'Onghia. Granulocytapheresis. Giornale di Tecniche Nefrologiche e Dialitiche 2013; 25(4_suppl) doi: 10.5301/GTND.2013.11333
|
| 82 |
Hossam M.M. Arafa, Ramadan A. Hemeida, Ali I.M. El-Bahrawy, Farid M.A. Hamada. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food and Chemical Toxicology 2009; 47(6) doi: 10.1016/j.fct.2009.03.003
|
| 83 |
Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Brian G. Feagan, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Marion Blank, Yinghua Lang, Jewel Johanns, Jean Frédéric Colombel, Daniel Present, Bruce E. Sands. Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies. Inflammatory Bowel Diseases 2012; 18(2) doi: 10.1002/ibd.21697
|
| 84 |
Chengchen Hu, Shengguo Wang, Zhi Gao, Maofeng Qing, Lian Tan, Lu Yang, Fang Li. Curcumin in oral health: mechanisms, clinical evidence, and delivery strategies. Frontiers in Pharmacology 2026; 16 doi: 10.3389/fphar.2025.1661443
|
| 85 |
Paul Aimé Noubissi, Queendoline Njilifac, Michel Archange Fokam Tagne, Mireille Sylviane Dongmo Nguepi, Angèle Foyet Fondjo, Nadège Kouémou Emégam, Joseph Ngakou Mukam, Roger Zintchem, Henri Wambe, Gaétan Olivier Fankem, Agathe Fotio Tonfack, Jean Paul Toukala, Germain Taiwe Sotoing, René Kamgamg. Anxiolytic and anti-colitis effects of Moringa oleifera leaf-aqueous extract on acetic acid-induced colon inflammation in rat. Biomedicine & Pharmacotherapy 2022; 154 doi: 10.1016/j.biopha.2022.113652
|
| 86 |
Francesca Borrelli, Gabriella Aviello, Barbara Romano, Pierangelo Orlando, Raffaele Capasso, Francesco Maiello, Federico Guadagno, Stefania Petrosino, Francesco Capasso, Vincenzo Di Marzo, Angelo A. Izzo. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. Journal of Molecular Medicine 2009; 87(11) doi: 10.1007/s00109-009-0512-x
|
| 87 |
Eleonora Franzè, Ivan Monteleone, Federica Laudisi, Angelamaria Rizzo, Vincenzo Dinallo, Davide Di Fusco, Alfredo Colantoni, Angela Ortenzi, Paolo Giuffrida, Sara Di Carlo, Giuseppe S Sica, Antonio Di Sabatino, Giovanni Monteleone. Cadherin-11 Is a Regulator of Intestinal Fibrosis. Journal of Crohn's and Colitis 2020; 14(3) doi: 10.1093/ecco-jcc/jjz147
|
| 88 |
Babak Saboury, Ali Salavati, Alex Brothers, Sandip Basu, Thomas C. Kwee, Marnix G. E. H. Lam, Roland Hustinx, Edouard Louis, Drew A. Torigian, Abass Alavi. FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. European Journal of Nuclear Medicine and Molecular Imaging 2014; 41(4) doi: 10.1007/s00259-013-2625-2
|
| 89 |
Alexandre Gherardi, Stéphane Roze, Johan Kuijvenhoven, Ola Ghatnekar, Yum Lina Yip Sonderegger. Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands. Journal of Medical Economics 2018; 21(9) doi: 10.1080/13696998.2018.1484371
|
| 90 |
Guilherme Grossi Lopes Cançado, Jacqueline Araújo Fiuza, Nivia Carolina Nogueira de Paiva, Lucas de Carvalho Dhom Lemos, Natasha Delaqua Ricci, Pedro Henrique Gazzinelli-Guimarães, Virgillio Gandra Martins, Daniella Castanheira Bartholomeu, Deborah Aparecida Negrão-Corrêa, Cláudia Martins Carneiro, Ricardo Toshio Fujiwara. Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice. Inflammatory Bowel Diseases 2011; 17(11) doi: 10.1002/ibd.21629
|
| 91 |
Kholoud Kh Kadry, Marwa M. Nagib, Ashaimaa Y. Moussa, Fadia S. Youssef, Manal S. Afifi. AMP-Activated Protein Kinase mediates the anti-inflammatory and antioxidant effects of Ceiba speciosa and Ceiba insignis in a rat model of ulcerative colitis. Journal of Ethnopharmacology 2025; 350 doi: 10.1016/j.jep.2025.119990
|
| 92 |
Jangeun An, Gyoungah Ryu, Seong-Ah Shin, Huiji Kim, Mi-Jeong Ahn, Jun Hyuck Lee, Chang Sup Lee. Wistin Exerts an Anti-Inflammatory Effect via Nuclear Factor-κB and p38 Signaling Pathways in Lipopolysaccharide-Stimulated RAW264.7 Cells. Molecules 2022; 27(17) doi: 10.3390/molecules27175719
|
| 93 |
Minjae Joo, Han Sang Kim, Tae Hoon Kwon, Alisha Palikhe, Tin Sandar Zaw, Ji Hoon Jeong, Uy Dong Sohn. Anti-inflammatory Effects of Flavonoids on TNBS-induced Colitis of Rats. The Korean Journal of Physiology & Pharmacology 2015; 19(1) doi: 10.4196/kjpp.2015.19.1.43
|
| 94 |
Richard C. Semelka MD, Miguel Ramalho MD. Mesenteric Panniculitis: A comprehensive review of imaging, clinical associations, and treatment approaches. Gastroenterology & Hepatology: Open access 2024; 15(5) doi: 10.15406/ghoa.2024.15.00592
|
| 95 |
Fernando Magro, Francisco Portela. Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies. BioDrugs 2010; 24 doi: 10.2165/11586290-000000000-00000
|
| 96 |
Su-Fen Huang, You-Cheng Shen, Ching-Hui Ou, I-Chu Tang, Han-Wen Yang, Yu-Ting Kao, Wen-Liang Chang, Tsu-Chung Chang. <i>Astragalus membranaceus</i> and <i>Panax notoginseng</i> saponins improves intestinal l-arginine absorption and protects against intestinal disorder <i>in vivo</i>. Food Science and Technology Research 2023; 29(2) doi: 10.3136/fstr.FSTR-D-22-00116
|
| 97 |
Simon P L Travis, Silvio Danese, Limas Kupcinskas, Olga Alexeeva, Geert D'Haens, Peter R Gibson, Luigi Moro, Richard Jones, E David Ballard, Johan Masure, Matteo Rossini, William J Sandborn. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut 2014; 63(3) doi: 10.1136/gutjnl-2012-304258
|
| 98 |
Mahnaz Fatahzadeh. Inflammatory bowel disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2009; 108(5) doi: 10.1016/j.tripleo.2009.07.035
|
| 99 |
Shammy Chandel, Ajay Prakash, Bikash Medhi. Current scenario in inflammatory bowel disease: Drug development prospects. Pharmacological Reports 2015; 67(2) doi: 10.1016/j.pharep.2014.09.005
|
| 100 |
Rutger D. Luteijn, Shivam A. Zaver, Benjamin G. Gowen, Stacia K. Wyman, Nick E. Garelis, Liberty Onia, Sarah M. McWhirter, George E. Katibah, Jacob E. Corn, Joshua J. Woodward, David H. Raulet. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature 2019; 573(7774) doi: 10.1038/s41586-019-1553-0
|
| 101 |
Mahboube Ganji-Arjenaki, Mahmoud Rafieian-Kopaei. Phytotherapies in inflammatory bowel disease. Journal of Research in Medical Sciences 2019; 24(1) doi: 10.4103/jrms.JRMS_590_17
|
| 102 |
Shengwu Ma, Anthony M. Jevnikar. Molecular Farming in Plants: Recent Advances and Future Prospects. 2012; doi: 10.1007/978-94-007-2217-0_2
|
| 103 |
Hiroyuki Hanai, Takayuki Iida, Ken Takeuchi, Hajime Arai, Osamu Arai, Jinrou Abe, Tatsuo Tanaka, Yasuhiko Maruyama, Kentarou Ikeya, Ken Sugimoto, Toshio Nakamura, Kouichi Nakamura, Fumitoshi Watanabe. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Digestive and Liver Disease 2012; 44(8) doi: 10.1016/j.dld.2012.03.007
|
| 104 |
Kajsa Edfors, Dagny Ståhlberg, Charlotte Söderman. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease. Therapeutic Apheresis and Dialysis 2016; 20(1) doi: 10.1111/1744-9987.12336
|
| 105 |
Fang WANG, Hai Ying ZHAO, Shu Tian ZHANG, You Zhe GONG, Hai Fang ZHANG, Chuan ZHANG. Effect of enteral nutrition on dextran sulfate sodium‐induced colitis in rats. Journal of Digestive Diseases 2011; 12(6) doi: 10.1111/j.1751-2980.2011.00518.x
|
| 106 |
Tiffany H Taft, Sarah Ballou, Laurie Keefer. A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease. Journal of Health Psychology 2013; 18(4) doi: 10.1177/1359105312446768
|
| 107 |
John J Miklavcic, Tasha DL Hart, Gordon M Lees, Glen K Shoemaker, Kareena L Schnabl, Bodil MK Larsen, Oliver F Bathe, Alan BR Thomson, Vera C Mazurak, M Tom Clandinin. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. World Journal of Gastroenterology 2015; 21(35): 10080-10090 doi: 10.3748/wjg.v21.i35.10080
|
| 108 |
Marcela A Hermoso, Rodrigo Quera, Gonzalo Astudillo, Mauricio Olivares-Morales, David Díaz-Jiménez, Alejandro Torres-Riquelme, Marjorie De la Fuente, Daniel Franco-Muñoz, Payton A Ottum, Karen Dubois-Camacho. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World Journal of Gastroenterology 2017; 23(36): 6628-6638 doi: 10.3748/wjg.v23.i36.6628
|
| 109 |
Xin Liu, Jianming Wang. Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. Journal of Ethnopharmacology 2011; 133(2) doi: 10.1016/j.jep.2010.11.010
|
| 110 |
Yan Zhang, Siyu Yu, Jia Liu, Ying Liu, Jie Luo, Yong Liu. A polysaccharide from Allium tenuissimum L. flowers relieves ulcerative colitis by regulating the inflammatory signaling pathway and gut microbiota. Food & Function 2023; 14(14) doi: 10.1039/D3FO01253K
|
| 111 |
Chandra P. Prasad, Gayatri Rath, Sandeep Mathur, Dinesh Bhatnagar, Ranju Ralhan. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines. Chemico-Biological Interactions 2010; 183(3) doi: 10.1016/j.cbi.2009.11.019
|
| 112 |
Peter McQueen, Kathleen Busman-Sahay, Florian Rieder, Laura Noël-Romas, Stuart McCorrister, Garrett Westmacott, Jacob D. Estes, Adam Burgener. Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction. Mucosal Immunology 2019; 12(6) doi: 10.1038/s41385-019-0200-2
|
| 113 |
Pratima Dibba, Megha Kothari, Irwin Grosman. Nutrition, Weight, and Digestive Health. 2022; doi: 10.1007/978-3-030-94953-2_11
|
| 114 |
Abbi R. Saniabadi, Tomotaka Tanaka, Takayuki Yamamoto, Wolfgang Kruis, Rodolfo Sacco. Granulomonocytapheresis as a cell‐dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes. Journal of Clinical Apheresis 2019; 34(1) doi: 10.1002/jca.21670
|
| 115 |
Mohamed A. Motagally, Shadia Neshat, Alan E. Lomax. Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009; 296(5) doi: 10.1152/ajpgi.00006.2009
|
| 116 |
Jennifer J Ryan, Douglas A Hanes, Ryan D Bradley, Nikhat Contractor. Effect of a Nutrition Support Formula in Adults With Inflammatory Bowel Disease: A Pilot Study. Global Advances in Health and Medicine 2019; 8 doi: 10.1177/2164956119867251
|
| 117 |
Monika Joshi, Manju Pandey, Ravi Shankar, Akash Ved. Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease. Current Pharmaceutical Biotechnology 2025; 26(8) doi: 10.2174/0113892010293150240415143650
|
| 118 |
B. G. Feagan, S. B. Hanauer, G. Coteur, S. Schreiber. Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol. Alimentary Pharmacology & Therapeutics 2011; 33(10) doi: 10.1111/j.1365-2036.2011.04636.x
|
| 119 |
Roger Yazbeck, Gordon S. Howarth, Catherine A. Abbott. Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?. Cytokine & Growth Factor Reviews 2009; 20(2) doi: 10.1016/j.cytogfr.2009.02.008
|
| 120 |
Niranjani Venkateswaran, Scott Weismiller, Kofi Clarke. Indeterminate Colitis – Update on Treatment Options. Journal of Inflammation Research 2021; doi: 10.2147/JIR.S268262
|
| 121 |
Sameer Lapsia, Siva Koganti, Salvatore Spadaro, Ramona Rajapakse, Anupama Chawla, Sumita Bhaduri‐McIntosh. Anti‐TNFα therapy for inflammatory bowel diseases is associated with Epstein‐Barr virus lytic activation. Journal of Medical Virology 2016; 88(2) doi: 10.1002/jmv.24331
|
| 122 |
Ayça Gökçen DEĞİRMENCİ SALTÜRK. İnflamatuvar Barsak Hastalarında Vedolizumab Deneyimi: Tek Merkez Verileri. Akademik Gastroenteroloji Dergisi 2022; 20(3) doi: 10.17941/agd.1005038
|
| 123 |
D F Godoi, C R Cardoso, D B Ferraz, P R Provinciatto, F Q Cunha, J S Silva, J C Voltarelli. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone Marrow Transplantation 2010; 45(10) doi: 10.1038/bmt.2010.6
|
| 124 |
Afrooz Mohammadgholi-Beiki, Mohammad Sheibani, Majid Jafari-Sabet, Manijeh Motevalian, Parvaneh Rahimi-Moghaddam. Anti-inflammatory and protective effects of Aripiprazole on TNBS-Induced colitis and associated depression in rats: Role of kynurenine pathway. International Immunopharmacology 2024; 133 doi: 10.1016/j.intimp.2024.112158
|
| 125 |
Rafat M. Mohareb, Gamal A. Elmegeed, Omar M.E. Abdel-Salam, Senot H. Doss, Marian G. William. Synthesis of modified steroids as a novel class of non-ulcerogenic, anti-inflammatory and anti-nociceptive agents. Steroids 2011; 76(10-11) doi: 10.1016/j.steroids.2011.05.011
|
| 126 |
Mengyi Zhou, Zhongqiu Wang, Jinping Chen, Yibei Zhan, Tao Wang, Lin Xia, Shiming Wang, Zichun Hua, Jianfa Zhang. Supplementation of the diet with Salecan attenuates the symptoms of colitis induced by dextran sulphate sodium in mice. British Journal of Nutrition 2014; 111(10) doi: 10.1017/S000711451300442X
|
| 127 |
Tanja Petreska Ivanovska, Maja Jurhar Pavlova, Kristina Mladenovska, Lidija Petrushevska-Tozi. Probiotics, prebiotics, synbiotics in prevention and treatment of inflammatory bowel diseases. Macedonian Pharmaceutical Bulletin 2014; 60(02) doi: 10.33320/maced.pharm.bull.2014.60.02.001
|
| 128 |
C. Bleau, A. Monges, K. Rashidan, J.-P. Laverdure, M. Lacroix, M.-R. Van Calsteren, M. Millette, R. Savard, L. Lamontagne. Intermediate chains of exopolysaccharides fromLactobacillus rhamnosusRW-9595M increase IL-10 production by macrophages. Journal of Applied Microbiology 2010; 108(2) doi: 10.1111/j.1365-2672.2009.04450.x
|
| 129 |
Alexandra-Chloe Villani, Denis Franchimont. La reconnaissance des bactéries de la flore intestinale. médecine/sciences 2010; 26(1) doi: 10.1051/medsci/201026136
|
| 130 |
C. López-Alarcón, E. Lissi, P. Hoffmann, J. Mella, C.D. Pessoa-Mahana, H. Speisky, M. Möller, G. Ferrer-Sueta, A. Denicola. Interaction of 5-aminosalicylic acid with nitrous acid: formation of the diazonium derivative and nitric oxide release. Canadian Journal of Chemistry 2011; 89(6) doi: 10.1139/v11-056
|
| 131 |
A Parikh, E Fedyk, D Soler, T Wyant, V Kadambi, T Leach, C Milch, I Fox. Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to the alpha4beta7 integrin. Inflammatory Bowel Diseases 2008; 14 doi: 10.1097/00054725-200812001-00060
|
| 132 |
Joo Yeon Kim, Tram Anh Ngoc Le, So Young Lee, Dae-Geun Song, Sung-Chul Hong, Kwang Hyun Cha, Jae Wook Lee, Cheol-Ho Pan, Kyungsu Kang. 3,3′-Diindolylmethane Improves Intestinal Permeability Dysfunction in Cultured Human Intestinal Cells and the Model Animal Caenorhabditis elegans. Journal of Agricultural and Food Chemistry 2019; 67(33) doi: 10.1021/acs.jafc.9b03039
|
| 133 |
Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem. A review article of inflammatory bowel disease treatment and pharmacogenomics. Beni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-023-00361-0
|
| 134 |
Samet Özdemir, Burcu Üner, Juste Baranauskaite, Engin Sümer, Ecem Yıldırım, Aylin Yaba. Design and characterization of dexamethasone loaded microsponges for the management of ulcerative colitis. European Journal of Pharmaceutics and Biopharmaceutics 2023; 187 doi: 10.1016/j.ejpb.2023.04.007
|
| 135 |
Yang Yang, Xiechen Zhou, Guiyan Jia, Tao Li, Yan Li, Rui Zhao, Ying Wang. Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L. polysaccharide against ulcerative colitis. Computers in Biology and Medicine 2023; 161 doi: 10.1016/j.compbiomed.2023.106999
|
| 136 |
Mary E Sherlock, John K MacDonald, Anne Marie Griffiths, A Hillary Steinhart, Cynthia H Seow. Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2015; 2015(10) doi: 10.1002/14651858.CD007698.pub3
|
| 137 |
Hanan S. El-Abhar, Lamiaa N.A. Hammad, Hala S. Abdel Gawad. Modulating effect of ginger extract on rats with ulcerative colitis. Journal of Ethnopharmacology 2008; 118(3) doi: 10.1016/j.jep.2008.04.026
|
| 138 |
Manjinder Singh Phull, Surender Singh Jadav, Chander Singh Bohara, Rambabu Gundla, Prathama S Mainkar. Continuous flow process for preparing budesonide. Journal of Flow Chemistry 2022; 12(2) doi: 10.1007/s41981-022-00221-5
|
| 139 |
Bas Kremer, Rob Mariman, Marjan van Erk, Tonny Lagerweij, Lex Nagelkerken, Benoit Foligne. Temporal Colonic Gene Expression Profiling in the Recurrent Colitis Model Identifies Early and Chronic Inflammatory Processes. PLoS ONE 2012; 7(11) doi: 10.1371/journal.pone.0050388
|
| 140 |
Lin Chen, Xue Han, Xiaohong Xu, Quan Zhang, Yingchun Zeng, Qing Su, Yujie Liu, Yanmei Sheng, Xingliang Xie. Optimization and Evaluation of the Thermosensitive In Situ and Adhesive Gel for Rectal Delivery of Budesonide. AAPS PharmSciTech 2020; 21(3) doi: 10.1208/s12249-020-1631-5
|
| 141 |
Mee Joo, Robert D. Odze. Rectal Sparing and Skip Lesions in Ulcerative Colitis: A Comparative Study of Endoscopic and Histologic Findings in Patients Who Underwent Proctocolectomy. American Journal of Surgical Pathology 2010; 34(5) doi: 10.1097/PAS.0b013e3181db84cd
|
| 142 |
Satoshi Yamada, Takuya Yoshino, Minoru Matsuura, Masamichi Kimura, Yorimitsu Koshikawa, Naoki Minami, Takahiko Toyonaga, Yusuke Honzawa, Hiroshi Nakase. Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis. Intestinal Research 2015; 13(3) doi: 10.5217/ir.2015.13.3.250
|
| 143 |
Yimin Pan, Zhichen Liu, Changwu Wu. Pan-Cancer Characterization Identifies SLC19A1 as an Unfavorable Prognostic Marker and Associates It with Tumor Infiltration Features. Biomedicines 2025; 13(3) doi: 10.3390/biomedicines13030571
|
| 144 |
Abigail R. Cannon, Suhail Akhtar, Adam M. Hammer, Niya L. Morris, Michael J. Javorski, Xiaoling Li, Richard H. Kennedy, Richard L. Gamelli, Mashkoor A. Choudhry. Effects of Mesalamine Treatment on Gut Barrier Integrity After Burn Injury. Journal of Burn Care & Research 2016; 37(5) doi: 10.1097/BCR.0000000000000396
|
| 145 |
Wangting Zhou, Xuhui Kan, Guijie Chen, Yi Sun, Linwu Ran, Yamei Yan, Jia Mi, Lu Lu, Xiaoxiong Zeng, Youlong Cao. The polysaccharides from the fruits of Lycium barbarum L. modify the gut community profile and alleviate dextran sulfate sodium-induced colitis in mice. International Journal of Biological Macromolecules 2022; 222 doi: 10.1016/j.ijbiomac.2022.10.015
|
| 146 |
Fridrik Thor Sigurbjörnsson, Ingvar Bjarnason. Leukocytapheresis for the treatment of IBD. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(9) doi: 10.1038/ncpgasthep1209
|
| 147 |
Oscar Brunser, Martin Gotteland. Bioactive Foods in Promoting Health. 2010; doi: 10.1016/B978-0-12-374938-3.00006-2
|
| 148 |
Mark T. Osterman, Kevin Haynes, Elizabeth Delzell, Jie Zhang, Meenakshi Bewtra, Colleen Brensinger, Lang Chen, Fenlong Xie, Jeffrey R. Curtis, James D. Lewis. Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease. Clinical Gastroenterology and Hepatology 2014; 12(5) doi: 10.1016/j.cgh.2013.06.010
|
| 149 |
Tosan Peter Omayone, Samuel Babafemi Olaleye. Biochemical and histopathological effects of low dose vanadium in the healing of acetic acid-induced colitis in male wistar rats. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(3) doi: 10.1515/jbcpp-2020-0246
|
| 150 |
Vita D'Amico, Ilaria Arduino, Mirco Vacca, Rosa Maria Iacobazzi, Davide Altamura, Antonio Lopalco, Rosanna Rizzi, Annalisa Cutrignelli, Valentino Laquintana, Franco Massimo, Maria De Angelis, Nunzio Denora, Angela Assunta Lopedota. Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation. Carbohydrate Polymers 2023; 302 doi: 10.1016/j.carbpol.2022.120422
|
| 151 |
Maddalena Sguizzato, Francesca Ferrara, Nada Baraldo, Agnese Bondi, Annunziata Guarino, Markus Drechsler, Giuseppe Valacchi, Rita Cortesi. Bilosomes and Biloparticles for the Delivery of Lipophilic Drugs: A Preliminary Study. Antioxidants 2023; 12(12) doi: 10.3390/antiox12122025
|
| 152 |
Joëlle St-Pierre, Kris Chadee. How the Discovery of TNF-α Has Advanced Gastrointestinal Diseases and Treatment Regimes. Digestive Diseases and Sciences 2014; 59(4) doi: 10.1007/s10620-014-3042-5
|
| 153 |
Suong Tran, Roderick S. Hooker, Daisha J. Cipher, Andreas Reimold. Patterns of Biologic Agent Use in Older Males with Inflammatory Diseases. Drugs & Aging 2009; 26(7) doi: 10.2165/11316350-000000000-00000
|
| 154 |
Md. Zahangir Hosain, Kazuki Yuzuriha, Khadijah Khadijah, Masafumi Takeo, Akihiro Kishimura, Yoshihiko Murakami, Takeshi Mori, Yoshiki Katayama. Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer–lipid hybrid nanoparticles. MedChemComm 2017; 8(7) doi: 10.1039/C7MD00174F
|
| 155 |
Dafina Nikolova. Inflammatory bowel disease and diet: Is there a place for probiotics?. Galenika Medical Journal 2023; 2(5) doi: 10.5937/Galmed2305041N
|
| 156 |
Annelie Lindberg, Michael Eberhardson, Mats Karlsson, Per Karlén. Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-73
|
| 157 |
Caroline Morin, Pierre U. Blier, Samuel Fortin. MAG-EPA reduces severity of DSS-induced colitis in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(10) doi: 10.1152/ajpgi.00136.2015
|
| 158 |
S. Danese, C. A. Siegel, L. Peyrin‐Biroulet. Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis. Alimentary Pharmacology & Therapeutics 2014; 39(10) doi: 10.1111/apt.12712
|
| 159 |
Dhir Gala, Taylor Newsome, Nicole Roberson, Soo Min Lee, Marvel Thekkanal, Mili Shah, Vikash Kumar, Praneeth Bandaru, Vijay Gayam. Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview. Diseases 2022; 10(4) doi: 10.3390/diseases10040073
|
| 160 |
A. Lubbad, M. A. Oriowo, I. Khan. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Molecular and Cellular Biochemistry 2009; 322(1-2) doi: 10.1007/s11010-008-9949-4
|
| 161 |
Bruce E Sands, Seymour Katz, Douglas C Wolf, Brian G Feagan, Tao Wang, Lisa-Marie Gustofson, Cindy Wong, Margaret K Vandervoort, Stephen Hanauer. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease. Gut 2013; 62(9) doi: 10.1136/gutjnl-2011-300995
|
| 162 |
Anouk Kaulmann, Torsten Bohn, Vasantha Rupasinghe. Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases—Promises, Perspectives, and Pitfalls. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/9346470
|
| 163 |
A comprehensive review on racecadotril drug. International Journal of Biosciences (IJB) 2019; doi: 10.12692/ijb/15.2.405-413
|
| 164 |
Jacqueline F. De Luca, Richard Severino, Yun Sun Lee, Douglas Johnson. Dermatologist and gastroenterologist awareness of the potential of immunosuppressants used to treat inflammatory bowel disease to cause non‐melanoma skin cancer. International Journal of Dermatology 2013; 52(8) doi: 10.1111/j.1365-4632.2012.5612.x
|
| 165 |
Mohmmad E. Rabeh, Lalitkumar K. Vora, Jessica V. Moore, Mohammad F. Bayan, Colin P. McCoy, Matthew P. Wylie. Dual stimuli-responsive delivery system for self-regulated colon-targeted delivery of poorly water-soluble drugs. Biomaterials Advances 2024; 157 doi: 10.1016/j.bioadv.2023.213735
|
| 166 |
Robert E. Post, Barry L. Hainer. Management of Antimicrobials in Infectious Diseases. 2010; doi: 10.1007/978-1-60327-239-1_12
|
| 167 |
J. Rafael Montenegro-Burke, Bernard P. Kok, Carlos Guijas, Xavier Domingo-Almenara, Clara Moon, Andrea Galmozzi, Seiya Kitamura, Lars Eckmann, Enrique Saez, Gary E. Siuzdak, Dennis W. Wolan. Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites. Science Signaling 2021; 14(702) doi: 10.1126/scisignal.abf6584
|
| 168 |
Kerstin C. Reuter, Stefan M. Loitsch, Axel U. Dignass, Dieter Steinhilber, Jürgen Stein, Giovambattista Pani. Selective Non-Steroidal Glucocorticoid Receptor Agonists Attenuate Inflammation but Do Not Impair Intestinal Epithelial Cell Restitution In Vitro. PLoS ONE 2012; 7(1) doi: 10.1371/journal.pone.0029756
|
| 169 |
Rafaela Mazieiro, Renata Reis Frizon, Sandra Maria Barbalho, Ricardo de Alvares Goulart. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?. Journal of Medicinal Food 2018; 21(11) doi: 10.1089/jmf.2017.0146
|
| 170 |
Sangmin Lee, Megan Crowe, Cynthia H Seow, Paulo G Kotze, Gilaad G Kaplan, Amy Metcalfe, Amanda Ricciuto, Eric I Benchimol, M Ellen Kuenzig. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD012711.pub2
|
| 171 |
Naveed T. Siddiqui, Howard Fischer, Laarni Guerina, Zeev Friedman. Effect of a Preoperative Gabapentin on Postoperative Analgesia in Patients with Inflammatory Bowel Disease Following Major Bowel Surgery: A Randomized, Placebo‐Controlled Trial. Pain Practice 2014; 14(2) doi: 10.1111/papr.12058
|
| 172 |
David Benharush, Matan J Cohen, Yair Kasirer, Dan Turner. Short chain fatty acids (butyrate) for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2010; doi: 10.1002/14651858.CD008730
|
| 173 |
Amjad Ahmadi, Rasoul Yousefimashouf, Asadollah Mohammadi, Bahram Nikkhoo, Leili Shokoohizadeh, Mohammadali Khan Mirzaei, Mohammad Yousef Alikhani, Farshad Sheikhesmaili, Hakim Khodaei. Investigating the expression of anti/pro-inflammatory cytokines in the pathogenesis and treatment of ulcerative colitis and its association with serum level of vitamin D. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87551-1
|
| 174 |
Daniel C Baumgart. What’s new in inflammatory bowel disease in 2008?. World Journal of Gastroenterology 2008; 14(3): 329-330 doi: 10.3748/wjg.14.329
|
| 175 |
Helieh S. Oz, Jeffrey L. Ebersole. Application of Prodrugs to Inflammatory Diseases of the Gut. Molecules 2008; 13(2) doi: 10.3390/molecules13020452
|
| 176 |
Siddhartha Kumar Mishra, Ju-Hee Kang, Dong-Kyu Kim, Seung Hyun Oh, Mi Kyung Kim. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. Journal of Ethnopharmacology 2012; 143(2) doi: 10.1016/j.jep.2012.07.008
|
| 177 |
Daniel Ginard, Zoe Mariño. ¿Tengo que premedicar a todos los pacientes cuando les pongo infliximab para disminuir las reacciones infusionales y/o la inmunogenicidad?. Gastroenterología y Hepatología 2008; 31(8) doi: 10.1157/13127101
|
| 178 |
Shushu Wang, Yuanyuan Xie, Xiaodi Yang, Xuesong Wang, Ke Yan, Zhengrong Zhong, Xiaowei Wang, Yuanhong Xu, Yi Zhang, Fang Liu, Jilong Shen. Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice. Parasites & Vectors 2016; 9(1) doi: 10.1186/s13071-015-1288-1
|
| 179 |
Srinivas Mutalik, Neelam A. Suthar, Renuka S. Managuli, Pallavi K. Shetty, Kiran Avadhani, Guruprasad Kalthur, Raghavendra V. Kulkarni, Ranjeny Thomas. Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. International Journal of Biological Macromolecules 2016; 86 doi: 10.1016/j.ijbiomac.2015.11.092
|